RG
LXRX icon

Rathbones Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Rathbones Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,283
Closed -$42K – 328
2015
Q1 		$42K Hold
6,283
– – ﹤0.01% 324
2014
Q4 		$40K Hold
6,283
– – ﹤0.01% 322
2014
Q3 		$62K Hold
6,283
– – ﹤0.01% 299
2014
Q2 		$71K Hold
6,283
– – 0.01% 281
2014
Q1 		$76K Hold
6,283
– – 0.01% 275
2013
Q4 		$79K Hold
6,283
– – 0.01% 199
2013
Q3 		$105K Hold
6,283
– – 0.01% 248
2013
Q2 		$95K Buy
+6,283
New +$95.5K 0.01% 229

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

Rathbones Group's LXRX Position: Q2 2015 in Review

Rathbones Group sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2015, closing a stake of 6,283 shares — an estimated $42K sold.

Rathbones Group first reported a position in LXRX in Q2 2013 and held it in 8 quarters. The position peaked at $105K in Q3 2013. 94 funds tracked by Wall St. Rank hold LXRX as of Q2 2015.

  • Rathbones Group reported no remaining Lexicon Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Rathbones Group sold 6,283 Lexicon Pharmaceuticals shares in Q2 2015, an estimated $42K.
  • Rathbones Group first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Rathbones Group's Lexicon Pharmaceuticals position peaked at $105K in Q3 2013.
  • 94 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2015.

Based on Rathbones Group's 13F filing for Q2 2015, filed 5 Aug 2015.